Gary Steinberg

Direktor/Vorstandsmitglied bei Cambridge Science Corp.

72 Jahre

Finance

Health Technology

Profil

Gary Steinberg is currently a Director at Cambridge Science Corp.
He was previously an Independent Non-Executive Director at Sole Realisation Company Plc from 2007 to 2010.

Aktive Positionen von Gary Steinberg

Unternehmen	Position	Beginn
Cambridge Science Corp. Cambridge Science Corp. BiotechnologyHealth Technology Cambridge Science Corp. engages in investing in the medicine. It also engages in improving patient lives through the acceleration of translational research and develops internal drug development programs. The firm finances and manages biotech companies commercializing novel technologies developed in the labs and the research institutions. The company was founded in 2017 and is headquartered in Cambridge, MA.	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Gary Steinberg

Ehemalige bekannte Positionen von Gary Steinberg

Unternehmen	Position	Ende
SOLE REALISATION COMPANY PLC	Direktor/Vorstandsmitglied	12.01.2010

Sehen Sie sich die Erfahrung von Gary Steinberg im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Gary Steinberg im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Sole Realisation Company Plc Sole Realisation Company Plc Investment ManagersFinance Sole Realisation Company Plc engages in the investment in private equity funds. The company was founded on June 12, 1995 and is headquartered in London, the United Kingdom.	Finance
Cambridge Science Corp. Cambridge Science Corp. BiotechnologyHealth Technology Cambridge Science Corp. engages in investing in the medicine. It also engages in improving patient lives through the acceleration of translational research and develops internal drug development programs. The firm finances and manages biotech companies commercializing novel technologies developed in the labs and the research institutions. The company was founded in 2017 and is headquartered in Cambridge, MA.	Health Technology